Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD 21702, USA.
Virus Isolation and Serology Laboratory, Frederick National Laboratory, Frederick, MD 21702, USA.
Viruses. 2021 Nov 22;13(11):2331. doi: 10.3390/v13112331.
We have recently reported that a recombinant HIV-1NL4.3 containing Met-to-Ile change at codon 50 of integrase (IN) (IN:M50I) exhibits suppression of the virus release below 0.5% of WT HIV, and the released viral particles are replication-incompetent due to defects in Gag/GagPol processing by inhibition of the initiation of autoprocessing of GagPol polyproteins in the virions and leads to replication-incompetent viruses. The coexisting Ser-to-Asn change at codon 17 of IN or Asn-to-Ser mutation at codon 79 of RNaseH (RH) compensated the defective IN:M50I phenotype, suggesting that both IN and RH regulate an HIV infectability. In the current study, to elucidate a distribution of the three mutations during anti-retroviral therapy among patients, we performed a population analysis using 529 plasma virus RNA sequences obtained through the MiSeq. The result demonstrated that 14 plasma HIVs contained IN:M50I without the compensatory mutations. Comparing the sequences of the 14 viruses with that of the defective virus illustrated that only Val-to-Ile change at codon 151 of IN (IN:V151I) existed in the recombinant virus. This IN:V151I is known as a polymorphic mutation and was derived from HIVNL4.3 backbone. A back-mutation at 151 from Ile-to-Val in the defective virus recovered HIV replication capability, and Western Blotting assay displayed that the back-mutation restored Gag/GagPol processing in viral particles. These results demonstrate that a combination of IN:M50I and IN:V151I mutations, but not IN:M50I alone, produces a defective virus.
我们最近报道了一种含有整合酶(IN)第 50 位密码子由蛋氨酸突变为异亮氨酸(IN:M50I)的重组 HIV-1NL4.3,其病毒释放被抑制在 WT HIV 的 0.5%以下,且由于 Gag/GagPol 加工过程中存在缺陷,释放的病毒颗粒无复制能力,这是由于抑制了病毒粒子中 GagPol 多蛋白的自我切割起始,从而导致复制缺陷型病毒。IN 的第 17 位密码子丝氨酸突变为天冬酰胺或 RNaseH(RH)的第 79 位天冬酰胺突变为丝氨酸的共存变化补偿了缺陷型 IN:M50I 表型,表明 IN 和 RH 都调节 HIV 的感染性。在本研究中,为了阐明在接受抗逆转录病毒治疗的患者中三种突变的分布情况,我们使用通过 MiSeq 获得的 529 个血浆病毒 RNA 序列进行了群体分析。结果表明,14 个血浆 HIV 中含有没有补偿性突变的 IN:M50I。将这 14 种病毒的序列与缺陷病毒的序列进行比较,结果表明只有 IN 的第 151 位密码子由缬氨酸突变为异亮氨酸(IN:V151I)。这种 IN:V151I 是一种多态性突变,源自 HIVNL4.3 骨架。在缺陷病毒中,151 位由异亮氨酸回突变为缬氨酸,恢复了 HIV 复制能力,Western Blotting 检测显示回突变回恢复了病毒颗粒中 Gag/GagPol 的加工。这些结果表明,只有 IN:M50I 和 IN:V151I 突变的组合,而不是单独的 IN:M50I,会产生缺陷型病毒。